shutterstock_96721225_steve_heap
Steve Heap / Shutterstock.com
5 October 2023FeaturesAmericasVincent Shier

'Cellect': why patent term adjustment is ripe for review

Following the Federal Circuit decision on In re Cellect—a dispute centred on Cellect’s allegations against Samsung Electronics for patent infringement—I wrote about why this outcome cannot be ignored.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
28 September 2023   A Federal Circuit decision provides lessons on why inaction over patent terms may risk incurable invalidation of important patents, writes Vincent Shier of Haynes Boone.

More on this story

Big Pharma
28 September 2023   A Federal Circuit decision provides lessons on why inaction over patent terms may risk incurable invalidation of important patents, writes Vincent Shier of Haynes Boone.

More on this story

Big Pharma
28 September 2023   A Federal Circuit decision provides lessons on why inaction over patent terms may risk incurable invalidation of important patents, writes Vincent Shier of Haynes Boone.